Clinicopathological assessment of PD-1/PD-L1 immune checkpoint expression in desmoid tumors

The details of immune molecules' expression in desmoid tumors (DTs) remain unclear. This study aimed to determine the expression status of the programmed death-1/programmed death ligand 1 (PD1/PD-L1) immune checkpoint mechanism in DTs. The study included patients with DTs (n=9) treated at our i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Kazuhiko, Nishimura, Shunji, Shinyashiki, Yu, Ito, Tomohiko, Kakinoki, Ryosuke, Akagi, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184173/
https://www.ncbi.nlm.nih.gov/pubmed/37098880
http://dx.doi.org/10.4081/ejh.2023.3688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184173/
https://www.ncbi.nlm.nih.gov/pubmed/37098880
http://dx.doi.org/10.4081/ejh.2023.3688

Ejemplares similares